Cost analysis for CPT 0340U — Dna assays for detection of minimal residual disease in cancer
Average Medicare Payment
$3837.98
2023 data
Total Payments (2023)
$52.9M
Services (2023)
13.8K
Price Change (2022–2023)
+0.8%
| Year | Avg Payment | Total Payments | Services | YoY Change |
|---|---|---|---|---|
| 2022 | $3806.70 | $9.0M | 2.4K | — |
| 2023 | $3837.98 | $52.9M | 13.8K | +0.8% |
The most expensive state pays 1.0x more than the cheapest for this procedure. CA averages $3837.98 vs CA at $3837.98.
| State | Avg Payment | Total Payments | Services | Providers |
|---|---|---|---|---|
| CA | $3837.98 | $52.9M | 13.8K | 1 |
| Provider | Specialty | State | Payments | Services | Avg/Service |
|---|---|---|---|---|---|
| Natera, Inc. | Clinical Laboratory | CA | $52.9M | 13.8K | $3837.98 |
Based on the data, CPT 0340U shows a 1.0x variation in pricing across states — relatively consistent by Medicare standards.
Costs have increased 0.8% since 2022. Medicare's fee schedule attempts to standardize pricing, though some variation is expected due to geographic cost-of-living adjustments and practice expense differences.
This analysis is based on publicly available CMS data and does not account for patient complexity, comorbidities, or facility-specific factors that may justify pricing differences.
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.